Zimmer Biomet Holdings ZBH Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 283.3%-3.7pp | 286.9%+0.2pp | 286.7%+4.3pp | 282.5%+24.7pp | |
| Operating margin | 63.1%-2.9pp | 66%+11.5pp | 54.5%+7.6pp | 46.9%-9.5pp | |
| Net margin | 41%-11.2pp | 52.2%— | —— | —— | |
| Returns | |||||
| Return on equity | 25.8%-5.8pp | 31.7%— | —— | —— | |
| Return on invested capital | 23.3%-3.5pp | 26.8%+4.5pp | 22.3%+4.9pp | 17.5%-3.1pp | |
| Efficiency | |||||
| Asset turnover | 1.4×0.0× | 1.4×+0.1× | 1.4×+0.1× | 1.2×+0.1× | |
| Liquidity | |||||
| Current ratio | 8.7×+2.5× | 6.2×-1.4× | 7.6×+0.2× | 7.4×-0.1× | |
| Leverage | |||||
| Debt-to-equity | 2.4×+0.5× | 2×+0.1× | 1.9×-0.1× | 2×-0.4× | |
| Net debt / EBITDA | 11.6×+1.5× | 10.2×-1.1× | 11.3×-1.5× | 12.8×-2.0× | |
| Per Share | |||||
| Book value per share | $253.30+3.4% | $244.93+3.9% | $235.78+2.4% | $230.20-3.9% | |
| Valuation | |||||
| Market capitalization | $78.13B-16.0% | $93.03B-12.8% | $106.65B+9.2% | $97.68B-19.0% | |
| Price / earnings | 96.4×+1.7× | 94.7×— | —— | —— | |
| Price / sales | 9.9×-2.5× | 12.3×-2.4× | 14.7×+0.6× | 14.1×-3.0× | |
| Price / book | 6.2×-1.2× | 7.4×-1.2× | 8.6×+0.5× | 8.1×-1.5× | |
| EV / EBITDA | 45.5×-6.6× | 52.1×-15.1× | 67.3×-1.8× | 69.1×-10.3× | |
| Dividend yield | 4%+0.5pp | 3.4%+0.4pp | 3%-0.3pp | 3.3%+0.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Zimmer Biomet Holdings's profit margins?
- Zimmer Biomet Holdings (ZBH) runs a 70.0% gross margin and a 14.0% operating margin, with a 9.1% net margin.
- Where do Zimmer Biomet Holdings's ratios come from?
- Every ratio is computed from Zimmer Biomet Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
